CSI Market
Sign In | Register

Galmed Pharmaceuticals Ltd (GLMD) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access GLMD Annual Balance Sheets →
Changes in quarterly balance sheet trends offer perspective on how Galmed Pharmaceuticals Ltd balances growth, leverage, and shareholder equity.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
0 0 0 (Dec 31 2024)
Assets
Cash & cash equivalent3.99
Marketable Securities, Current SH7.33
Deposits Assets, Current AS7.15
Cash & Short-term Investments17.00
Accounts receivable0.00
Other Receivables, Net, Current0.35
Other Current Assets0.12
Total loans net0.27
Total Current Assets18.63
Equipment/Property/Plant Net0.00
Long-term investments0.00
Tax Assets, Noncurrent205.90
Other Assets, Noncurrent0.00
Total Assets18.63
Liabilities
Accounts Payable, Current AC2.00
Accrued Liabilities, Current0.28
Other Loans Payable, Current OT0.84
Total Current Liabilities2.85
Long-term debt0.00
Total Long-term Debt0.00
Total Liabilities2.84
Stockholders' Equity
Common Stock Value3.41
Additional Paid In Capital Common Stock223.46
Retained Earnings / Accumulated Deficit-210.78
Accumulated Other Comprehensive Income-0.30
Other Equity-0.30
Common Stockholder's Equity15.78
Total Stockholder's Equity15.78
Liabilities & Stockholder's Equity18.63
4 historic quarters locked

Sign in to unlock the full Galmed Pharmaceuticals Ltd balance sheet history.

Sign In Create Free Account

About Galmed Pharmaceuticals Ltd Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 20-F (Period: 20251231)
  • Filed with the SEC: March 31, 2026
  • Source: form20-f.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-26-014182

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.